HM Payson & Co. lowered its position in shares of Express Scripts Holding Company (NASDAQ:ESRX) by 6.7% in the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 11,428 shares of the company’s stock after selling 820 shares during the period. HM Payson & Co.’s holdings in Express Scripts Holding were worth $730,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds and other institutional investors have also recently made changes to their positions in the company. Waldron LP acquired a new stake in Express Scripts Holding in the 1st quarter valued at approximately $206,000. DUPONT CAPITAL MANAGEMENT Corp increased its holdings in Express Scripts Holding by 9.2% in the 1st quarter. DUPONT CAPITAL MANAGEMENT Corp now owns 71,940 shares of the company’s stock valued at $4,742,000 after purchasing an additional 6,081 shares during the last quarter. Sumitomo Mitsui Asset Management Company LTD increased its holdings in Express Scripts Holding by 10.9% in the 1st quarter. Sumitomo Mitsui Asset Management Company LTD now owns 52,135 shares of the company’s stock valued at $3,436,000 after purchasing an additional 5,121 shares during the last quarter. Parsons Capital Management Inc. RI increased its holdings in Express Scripts Holding by 0.8% in the 1st quarter. Parsons Capital Management Inc. RI now owns 32,393 shares of the company’s stock valued at $2,135,000 after purchasing an additional 245 shares during the last quarter. Finally, Beaumont Financial Partners LLC acquired a new stake in Express Scripts Holding in the 1st quarter valued at approximately $351,000. Institutional investors and hedge funds own 88.71% of the company’s stock.

COPYRIGHT VIOLATION NOTICE: This story was published by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are accessing this story on another publication, it was copied illegally and reposted in violation of US and international copyright and trademark law. The correct version of this story can be accessed at https://www.thecerbatgem.com/2017/09/11/express-scripts-holding-company-esrx-stake-lessened-by-hm-payson-co.html.

In other Express Scripts Holding news, VP Everett Neville sold 1,163 shares of the firm’s stock in a transaction on Wednesday, August 23rd. The shares were sold at an average price of $61.48, for a total transaction of $71,501.24. Following the completion of the transaction, the vice president now directly owns 18,232 shares of the company’s stock, valued at approximately $1,120,903.36. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. 0.68% of the stock is owned by company insiders.

ESRX has been the subject of several research reports. Jefferies Group LLC set a $72.00 target price on shares of Express Scripts Holding and gave the company a “buy” rating in a report on Tuesday, August 29th. ValuEngine downgraded shares of Express Scripts Holding from a “buy” rating to a “hold” rating in a report on Friday, September 1st. Robert W. Baird reiterated a “hold” rating and issued a $56.00 target price on shares of Express Scripts Holding in a report on Friday, September 1st. Needham & Company LLC initiated coverage on shares of Express Scripts Holding in a report on Friday, July 21st. They issued a “hold” rating for the company. Finally, BidaskClub upgraded shares of Express Scripts Holding from a “sell” rating to a “hold” rating in a report on Saturday, June 17th. Four analysts have rated the stock with a sell rating, thirteen have issued a hold rating, five have assigned a buy rating and one has assigned a strong buy rating to the stock. Express Scripts Holding has a consensus rating of “Hold” and an average price target of $70.24.

Shares of Express Scripts Holding Company (NASDAQ:ESRX) opened at 62.90 on Monday. Express Scripts Holding Company has a 12 month low of $57.80 and a 12 month high of $77.50. The stock has a market capitalization of $36.33 billion, a PE ratio of 10.92 and a beta of 0.88. The company has a 50-day moving average of $61.85 and a 200-day moving average of $63.52.

Express Scripts Holding (NASDAQ:ESRX) last announced its quarterly earnings data on Tuesday, July 25th. The company reported $1.73 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $1.71 by $0.02. The company had revenue of $25.35 billion during the quarter, compared to analyst estimates of $25.52 billion. Express Scripts Holding had a net margin of 3.50% and a return on equity of 25.58%. The firm’s revenue for the quarter was up .5% compared to the same quarter last year. During the same period last year, the business earned $1.57 EPS. On average, equities research analysts expect that Express Scripts Holding Company will post $6.99 EPS for the current fiscal year.

About Express Scripts Holding

Express Scripts, Inc is a pharmacy benefit management (PBM) company in North America, offering a range of services to its clients, which include health insurers, third-party administrators, employers, union-sponsored benefit plans, workers’ compensation plans and government health programs. It operates in two segments: PBM and Emerging Markets (EM).

Institutional Ownership by Quarter for Express Scripts Holding (NASDAQ:ESRX)

Receive News & Stock Ratings for Express Scripts Holding Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Express Scripts Holding Company and related stocks with our FREE daily email newsletter.